Which sedative is safer during ERCP? a Head-to-Head trial

NCT ID NCT07702240

Not yet recruiting Symptom relief Sponsor: Ren Da Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial tests two drug combinations used to sedate people during a procedure called ERCP, which examines bile ducts. One group receives esketamine plus propofol, the other sufentanil plus propofol. Researchers track oxygen levels and blood pressure to see which approach causes fewer breathing or blood pressure problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: esketamine and sufentanil, each combined with propofol
What this could lead to: If esketamine proves safer, it could become a preferred sedative for ERCP, reducing breathing and blood pressure complications.
What could go wrong: This is a single-center trial, and results may not apply to all hospitals or patient groups. Both drugs have known side effects like nausea or dizziness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY TRACT DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia biliary tract disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILIARY TRACT DISEASES PROCEDURAL SEDATION AND ANALGESIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.